People · Operator
Named in public records as an officer, director or promoter · active 2010–2011 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| On Demand Therapeutics, Inc. | — | Biotechnology | Seed | $3.8M | $116.5M | 2010 |
Gil T. Kliman at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Gil T. Kliman on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Santini | 1 | 5 |
| Gil Kliman | 1 | 3 |
| Gordon Saul | 1 | 2 |
| John T. Santini, Jr. | 1 | 2 |
| Dave Weber | 1 | 1 |
| Charline Gauthier | 1 | 1 |
| Naveed Shams | 1 | 1 |
| Ajit T. Gill | 1 | 1 |
| David T. Weber | 1 | 1 |
| Gordon T. Saul | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.